ACTIVE

BIOWIN

Financial year 2025 · Closed on 31/12/2025

Net result
-13,4 k €
-142,5 %over 1 year
Gross margin
1,1 M €
+27,5 %over 1 year
Equity
300,8 k €
-4,3 %over 1 year
Workforce
7,6 ETP
+22,6 %over 1 year

Identity

Source · BCE/KBO

BIOWIN is a Non-profit organization incorporated in 2006. Its main activity is: Other professional, scientific and technical activities. Its registered office is in Namur. It employs on average 7,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0882.768.591
Incorporation
28/07/2006
Legal form
Non-profit organization
Registered office
Avenue d'Ecolys(RH) 2 box 29
5020 Namur · WallonieSee on map
Latest accounts
31/12/2025
Average workforce
7,6 ETP
Joint committees (1)
  • 337
Signals
Good liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 18 financial years

20252024202320222021
Income statement
Gross margin1,1 M €833,4 k €481,6 k €661,6 k €713,8 k €
EBITDA82,5 k €101,2 k €-115,7 k €121,4 k €133,6 k €
Operating result-8,3 k €82,2 k €-61,8 k €55,5 k €142,1 k €
Net result-13,4 k €31,6 k €-73 k €48,2 k €121,5 k €
Balance sheet
Equity300,8 k €314,2 k €282,7 k €355,7 k €307,5 k €
Total assets1,1 M €1,5 M €1,2 M €991,8 k €1,3 M €
Cash141,2 k €735,8 k €514,2 k €430,5 k €608,7 k €
Debts738,4 k €412,8 k €420,2 k €348,7 k €351 k €
Other
Workforce7,6 ETP6,2 ETP5,9 ETP5,9 ETP6,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

15 active · 146 ended

Active mandates

Ion Beam Applications

Director · since 12 juin 2025 · until 05 juin 2026 · 0428.750.985

Represented by Cristiana Gameiro-Paris

Active
NOVADIP BIOSCIENCES

Director · since 12 juin 2025 · until 05 juin 2026 · 0535.575.602

Represented by Denis Dufrane

Active
Telix Pharmaceuticals (Belgium)

Director · since 12 juin 2025 · until 05 juin 2026 · 0695.832.765

Represented by Sébastien Linard

Active
CER-Groupe

Director · since 15 juin 2023 · until 05 juin 2026 · 0420.654.158

Represented by OLIVIER VANLOOCKE

Active
COMUNICARE SOLUTIONS

Director · since 15 juin 2023 · until 05 juin 2026 · 0686.922.227

Represented by ALFRED ATTIPOE

Active
EXO Biologics

Director · since 15 juin 2023 · until 05 juin 2026 · 0732.982.379

Represented by HUGUES WALLEMACQ

Active
EYED PHARMA

Director · since 15 juin 2023 · until 05 juin 2026 · 0508.599.605

Represented by MELANIE MESTDAGT

Active
GlaxoSmithKline Biologicals

Director · since 15 juin 2023 · until 05 juin 2026 · 0440.872.918

Represented by PHILIPPE DENOEL

Active
KANEKA EUROGENTEC

Director · since 15 juin 2023 · until 05 juin 2026 · 0427.348.346

Represented by FLORENCE XHONNEUX

Active
UCB PHARMA

Director · since 15 juin 2023 · until 05 juin 2026 · 0403.096.168

Represented by Xavier Hormaechea

Active
Université Catholique de Louvain

Director · since 15 juin 2023 · until 05 juin 2026 · 0419.052.272

Represented by JEAN-CHRISTOPHE RENAULD

Active
Université de Liège - Communauté française

Director · since 15 juin 2023 · until 05 juin 2026 · 0807.970.507

Represented by BRIGITTE MALGRANGE

Active
UNIVERSITE DE MONS

Director · since 15 juin 2023 · until 05 juin 2026 · 0259.396.509

Represented by ANNE-EMILIE DECLEVES

Active
Université de Namur

Director · since 15 juin 2023 · until 05 juin 2026 · 0409.530.535

Represented by CARINE MICHIELS

Active
Université Libre de Bruxelles

Director · since 15 juin 2023 · until 05 juin 2026 · 0407.626.464

Represented by SERGE SCHIFFMANN

Active

Ended mandates

Barré

Director · since 15 juin 2023 · until 15 juin 2026 · 0448.409.224

Represented by JAVIER MARTINEZ

Ended
BAXALTA BELGIUM MANUFACTURING

Director · since 15 juin 2023 · until 15 juin 2026 · 0563.700.454

Represented by VALERIE DE SCHUTTER

Ended
CER-Groupe

Director · since 15 juin 2023 · until 15 juin 2026 · 0420.654.158

Represented by OLIVIER VANLOOCKE

Ended
COMUNICARE SOLUTIONS

Director · since 15 juin 2023 · until 15 juin 2026 · 0686.922.227

Represented by ALFRED ATTIPOE

Ended

Other companies at this address

Avenue d'Ecolys(RH) 2 5020 Namur
CompanyCBE no.
A.A.S.V.● Active
0430.121.358
Actibel Hôtel● Active
0654.752.968
0460.782.662
0673.597.395
ACTIONAM● Active
0440.996.840
ACTION II● Active
0449.242.236
A-DJ SERVICES● Active
0862.601.006
Annet 4 Future● Active
0791.919.678
Antech Belgium● Active
0820.954.154
0463.017.622
AQUALE● Active
0477.877.428
1021.551.738
0797.621.102
Aves TVA● Active
0804.855.718
A-Z ServiPro● Active
0462.702.668
BDG Ansotte● Active
1016.456.862
B.G.N INVEST● Active
0804.639.744
BN 4● Active
0859.854.619
CAVI● Active
0440.893.605
CCB & PARTNERS● Active
1016.343.927

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202618/07/202527/05/202528/08/202322/07/202209/08/2021
General meeting05/06/202612/06/202513/06/202415/06/202321/06/202207/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202505/06/202630/06/2026FrenchPDF
Abridged model31/12/202412/06/202518/07/2025FrenchPDF
Abridged modelCorrection31/12/202313/06/202427/05/2025FrenchPDF
Abridged model31/12/202313/06/202418/06/2024FrenchPDF
Abridged model31/12/202215/06/202328/08/2023FrenchPDF
Abridged model31/12/202121/06/202222/07/2022FrenchPDF
Abridged model31/12/202007/06/202109/08/2021FrenchPDF
Abridged model31/12/201917/06/202030/07/2020FrenchPDF
Abridged model31/12/201820/06/201908/08/2019FrenchPDF
Abridged model31/12/201713/06/201831/08/2018FrenchPDF
Abridged model31/12/201613/06/201727/07/2017FrenchPDF
Abridged model31/12/201503/06/201630/08/2016FrenchPDF
Abridged model31/12/201404/06/201530/06/2015FrenchPDF
Abridged model31/12/201316/06/201423/12/2014FrenchPDF
Abridged model31/12/201217/06/201323/07/2013FrenchPDF
Abridged model31/12/201114/05/201217/01/2013FrenchPDF
Abridged model31/12/201006/06/201102/05/2012FrenchPDF
Abridged model31/12/200927/05/201017/09/2010FrenchPDF
Abridged model31/12/200816/06/200908/01/2010FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

15 active · 146 ended

Active mandates

Ion Beam Applications

Director · since 12 juin 2025 · until 05 juin 2026 · 0428.750.985

Represented by Cristiana Gameiro-Paris

Active
NOVADIP BIOSCIENCES

Director · since 12 juin 2025 · until 05 juin 2026 · 0535.575.602

Represented by Denis Dufrane

Active
Telix Pharmaceuticals (Belgium)

Director · since 12 juin 2025 · until 05 juin 2026 · 0695.832.765

Represented by Sébastien Linard

Active
CER-Groupe

Director · since 15 juin 2023 · until 05 juin 2026 · 0420.654.158

Represented by OLIVIER VANLOOCKE

Active
COMUNICARE SOLUTIONS

Director · since 15 juin 2023 · until 05 juin 2026 · 0686.922.227

Represented by ALFRED ATTIPOE

Active
EXO Biologics

Director · since 15 juin 2023 · until 05 juin 2026 · 0732.982.379

Represented by HUGUES WALLEMACQ

Active
EYED PHARMA

Director · since 15 juin 2023 · until 05 juin 2026 · 0508.599.605

Represented by MELANIE MESTDAGT

Active
GlaxoSmithKline Biologicals

Director · since 15 juin 2023 · until 05 juin 2026 · 0440.872.918

Represented by PHILIPPE DENOEL

Active
KANEKA EUROGENTEC

Director · since 15 juin 2023 · until 05 juin 2026 · 0427.348.346

Represented by FLORENCE XHONNEUX

Active
UCB PHARMA

Director · since 15 juin 2023 · until 05 juin 2026 · 0403.096.168

Represented by Xavier Hormaechea

Active
Université Catholique de Louvain

Director · since 15 juin 2023 · until 05 juin 2026 · 0419.052.272

Represented by JEAN-CHRISTOPHE RENAULD

Active
Université de Liège - Communauté française

Director · since 15 juin 2023 · until 05 juin 2026 · 0807.970.507

Represented by BRIGITTE MALGRANGE

Active
UNIVERSITE DE MONS

Director · since 15 juin 2023 · until 05 juin 2026 · 0259.396.509

Represented by ANNE-EMILIE DECLEVES

Active
Université de Namur

Director · since 15 juin 2023 · until 05 juin 2026 · 0409.530.535

Represented by CARINE MICHIELS

Active
Université Libre de Bruxelles

Director · since 15 juin 2023 · until 05 juin 2026 · 0407.626.464

Represented by SERGE SCHIFFMANN

Active

Ended mandates

Barré

Director · since 15 juin 2023 · until 15 juin 2026 · 0448.409.224

Represented by JAVIER MARTINEZ

Ended
BAXALTA BELGIUM MANUFACTURING

Director · since 15 juin 2023 · until 15 juin 2026 · 0563.700.454

Represented by VALERIE DE SCHUTTER

Ended
CER-Groupe

Director · since 15 juin 2023 · until 15 juin 2026 · 0420.654.158

Represented by OLIVIER VANLOOCKE

Ended
COMUNICARE SOLUTIONS

Director · since 15 juin 2023 · until 15 juin 2026 · 0686.922.227

Represented by ALFRED ATTIPOE

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates07/08/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/12/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates20/02/2024
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates01/02/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Other21/11/2016
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates23/09/2016
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates20/02/2014
    DEMISSIONS, NOMINATIONS
    PDF
  • Other20/02/2014
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-13,4 k €↓
  2. 2024
    Annual accounts 202431,6 k €↑
  3. 2023
    Annual accounts 2023-73 k €↓
  4. 2022
    Annual accounts 202248,2 k €↓
  5. 2021
    Annual accounts 2021121,5 k €↑
  6. 2020
    Annual accounts 2020-9,4 k €↑
  7. 2019
    Annual accounts 2019-72,7 k €↓
  8. 2018
    Annual accounts 2018229,7 k €↑
  9. 2017
    Annual accounts 20171,2 k €↓
  10. 2016
    Annual accounts 201663,7 k €↓
  11. 2015
    Annual accounts 201572,2 k €↑
  12. 2014
    Annual accounts 2014-29 k €↑
  13. 2013
    Annual accounts 2013-192,2 k €↓
  14. 2012
    Annual accounts 201217 k €↑
  15. 2011
    Annual accounts 2011-83 k €↓
  16. 2010
    Annual accounts 2010101,9 k €↑
  17. 2009
    Annual accounts 2009-77,2 k €↓
  18. 2008
    Annual accounts 200876,6 k €
  19. 28/07/2006
    IncorporationNon-profit organization